Peer-Reviewed Journals
Twin Precision treatment is scientifically proved through an officially registered Clinical trial Registered on Clinical Trials Registry India (CTRI/2020/08/027072), which is globally recognized.
Twin Publications
04 June 2022
AI Offers Significant Rate of Remission for Diabetes
A new study on Whole Body Digital TwinTM reveals the highest reported rate of remission of type 2 diabetes to date.
9 September 2020
22nd European Congress of Endocrinology
Utilising internet of things and artificial intelligence to enable twin precision treatment for reversal of type 2 Diabetes
25 September 2020
Diabetes Therapy
Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis
ADA Journal Diabetes®, 2021
Diabetes, Effect of Digital Twin Technology for Remission of Diabetes on the Glycemic and Extra-Glycemic Parameters: Interim Results of the Prospective Randomised Controlled Clinical Trial
Journal of Diabetes Technology & Therapeutics, 2021
Digital Twin Technology Intervention to Achieve and Maintain the Glycemic Variability Within the Targets in T2DM– Insights from Real World Study, 14th International Conference on Advanced Technologies & Treatments for Diabetes, 2021
European Diabetic Nephropathy Study Group 2021
Relationship between Renal Function and Glycemic Changes in Type 2 Diabetes Mellitus: Initial Insights from the Randomised Trial Evaluating Whole-Body Digital Twin Technology Enabled Precision Nutrition for Reversal of Diabetes
European and International Congress on Obesity 2021
Relationship between Obesity, Insulin Resistance and Glycemic Changes in Type 2 Diabetes Mellitus: Initial Insights from the Randomised Trial Evaluating Whole-Body Digital Twin Technology Enabled Precision Nutrition for Reversal of Diabetes
International Society for Pharmacoeconomics and Outcomes Research, ISPOR 2021
Health Economic Analysis of Digital Twin Technology for Remission of Diabetes: Initial Insights from the Prospective Randomised Controlled Clinical Trial
European Heart Journal - Acute CardioVascular Care, 2021
Combined Improvement of Insulin Resistance and Hypertension Using Whole Body Digital Twin Technology in Diabetic Hypertensives- A Real World Study
Argentine Journal of Endocrinology and Metabolism, 2021
Correlation Between the Glycated Haemoglobin and HOMA Indices in Type 2 Diabetes Mellitus: Impact of Whole-Body Digital Twin Technology Enabled Precision Nutrition”, 19th International Congress of Endocrinology
Journal of the Endocrine Society, 2021 - ENDO 2021
Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 Weeks of the Ongoing Randomised Controlled Trial
Metabolism: Clinical and Experimental, Vol. 116, March 2021
Metabolic Benefits Beyond Glycemic Control with Improvement in Insulin Resistance and Testosterone: Impact of Twin Enabled Precision Nutrition
18th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
Metabolic Benefits Beyond Glycemic Control with Improvement in Insulin Resistance and Testosterone: Impact of Twin Enabled Precision Nutrition
ENDO 2021
Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 weeks
14th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) 2021
Digital Twin Technology Intervention To Achieve And Maintain The Glycemic Variability Within The Targets In T2DM– Insights From Real World Study
American Association of Clinical Endocrinology (AACE) 2021
Digital Twin Enabled Precision Nutrition Induces Remission of Diabetes Independent of Improvement in the Markers of Obesity
19th International Congress of Endocrinology (ICE 2021)
Correlation between the Glycated Hemoglobin and HOMA indices in Type 2 Diabetes Mellitus: Impact of Whole-Body Digital Twin Technology enabled Precision Nutrition
American Association of Clinical Endocrinology (AACE) 2021
Health Economic Analysis of Digital Twin Technology for Remission of Diabetes - Initial Insights from the Prospective Randomised Controlled Clinical Trial
ESC-ACVC 2021 ESC Acute CardioVascular Care 2021
Combined Improvement of Insulin Resistance and Hypertension Using Whole Body Digital Twin Technology in Diabetic Hypertensives- A Real World Study
My ESC - Your Technology - ESC Digital Summit 2021
Whole Body Digital Twin Technology for Reversal of Chronic Diseases with Simultaneous Benefits to Reduce the Burden of Cardiovascular Disease
ESC Asia with APSC & AFC 2021
Remission of T2DM by Digital Twin Technology with Reduction of Cardiovascular Risk: Interim Results of Randomised Controlled Clinical Trial
19th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) 2022
Glycemic Control with Improvement in HOMA2 IR and HOMA2 Beta: Impact of Digital Twin Enabled Precision Nutrition for Remission of Diabetes
International Diabetes Federation (IDF) Virtual Congress 2021
Remission of T2DM by Digital Twin Technology Across Indian and American Cohorts- Initial Insights from Real-World Study
15th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) 2022
Association of The Remission of T2DM by Digital Twin Technology with The Improvement In The Glycemic Metrics
3rd International Conference on Fatty Liver (ICFL) 2022
Digital Twin Technology For Remission Of Diabetes And Fatty Liver: Initial Results At 6 Months Of Follow up of The Prospective Randomised Controlled Clinical Trial
European Association for the Study of Obesity (EASO) 2022
Impact of Digital Twin technology based on Artificial Intelligence (AI) and Internet of Things (IoT) technologies on diabetes remission and correlation between progressive weight loss with Insulin resistance, waist circumference, and fasting insulin
American Association of Clinical Endocrinology (AACE) 2022
Predictors Of Type 2 Diabetes (T2D) Remission Using Digital Twin Technology Based On Artificial Intelligence (AI) And Internet Of Things (IoT) Technologies
American Diabetes Association (ADA) 2022, 82nd scientific sessions
Metabolic Benefits Beyond Glycemic Control with Artificial Intelligence, Internet of Things and Whole-Body Digital Twin - Initial six months Treatment
American Diabetes Association (ADA) 2022, 82nd scientific sessions
Normalisation of Glycemic and Extra-Glycemic Parameters with T2DM Remission: Insights from RCT enabled by Whole-Body Digital Twin Technology
ENDO 2022
Concordance between HbA1c, eA1C and fasting plasma glucose criteria to define diabetes remission: Insights from the Initial Six months of Digital Twin Intervention Trial
ENDO 2022
Effectiveness of Digital Twin Technology for the improvement in Depression among patients undergoing remission of Diabetes
European Society of Hypertension (ESH) 2022
Correlation Between Remission Of Diabetes And Reductions In Insulin Resistance, Blood Pressure And Cardiovascular Risk Scores: Results Of Six Months Of Randomised Trial With Digital Twin Technology
European Association for the Study of Diabetes (EASD) 2022
Correlation between the regression of microalbuminuria, Blood pressure reduction and remission of T2DM: Results of Six Month RCCT with Whole-Body Digital Twin Technology
Endocrine Abstracts Vol 70, Sep 2020
Utilising Internet of Things and Artificial Intelligence to Enable Twin Precision Treatment for Reversal of Type 2 Diabetes
Obes Facts 2021;14:1–154
Relationship between Obesity, Insulin Resistance and Glycemic Changes in Type 2 Diabetes Mellitus: Initial Insights from the Randomised Trial Evaluating Whole-Body Digital Twin Technology Enabled Precision Nutrition for Reversal of Diabetes
ADA Journal Diabetes®, 2021
Effect Of Digital Twin Technology For Remission Of Diabetes On The Glycemic And Extra Glycemic Parameters : Interim Results Of The Prospective Randomised Controlled Clinical Trial
Endocrine Practice, Journal For Clinical Endocrinology, 2021 (Abstract) Volume 27, Issue 6, Supplement , S68, June 01, 2021
Digital Twin Enabled Precision Nutrition Induces Remission of Diabetes Independent of Improvement in the Markers of Obesity
Endocrine Practice, Volume 27, Issue 12, Supplement , S7, December 01, 2021
Health Economic Analysis of Digital Twin Technology for Remission of Diabetes - Initial Insights from the Prospective Randomised Controlled Clinical Trial
European Heart Journal, 2022, 43(Suppl 1)
Remission of T2DM by Digital Twin Technology with Reduction of Cardiovascular Risk: Interim Results of Randomised Controlled Clinical Trial
Metabolism-Clinical and Experimental. 2022 Mar 1;128.
Glycemic Control with Improvement in HOMA2 IR and HOMA2 Beta: Impact of Digital Twin Enabled Precision Nutrition for Remission of Diabetes
Scientific Reports - Nature
Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program
Clinical Diabetes and Endocrinology
Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal